Company profile: Inogen
1.1 - Company Overview
Company description
- Provider of oxygen therapy solutions as a manufacturer and accredited homecare provider. Offers portable oxygen concentrators that replace tanks and deliveries, including Inogen One G5 (up to 13 hours), G4 (up to 5 hours), G3 (up to 10 hours), and INOGEN ROVE 6 (expected service life up to 8 years, designed for less than 8 hours of daily use), featuring Intelligent Delivery Technology that adapts to breathing rate, including during sleep.
Products and services
- Portable Oxygen Concentrators (POCs): Portable devices that concentrate oxygen from surrounding air, engineered to replace oxygen tanks and deliveries for oxygen therapy and mobile homecare
- Inogen One G5 System: Battery-powered concentrator engineered for extended mobility, delivering oxygen with up to 13 hours of runtime per charge for portable oxygen therapy
- Intelligent Delivery Technology: Adaptive component that adjusts oxygen dosing to the user's breathing rate, prioritizing efficiency and sustaining delivery during sleep for consistent therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inogen
Emphasys Medical
HQ: United States
Website
- Description: Provider of therapeutic devices for the treatment of patients with emphysema and other breathing disorders, offering the Zephyr Endobronchial Valve system designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emphasys Medical company profile →
Michigan Instruments
HQ: United States
Website
- Description: Provider of automated CPR devices, lung simulators, and head simulation modules for the healthcare industry; offering hands-on training, testing of respiratory care products and techniques, and advancing research and development. Its CPR chest compression machines deliver high-quality care during the treatment of cardiac arrest.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Michigan Instruments company profile →
Flyp
HQ: United States
Website
- Description: Provider of a portable medical device and an easier-to-follow treatment plan for COPD, asthma, and other respiratory conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flyp company profile →
Vivus
HQ: United States
Website
- Description: Provider of next-generation therapeutic products, including QSYMIA, a once-daily oral medication for weight management that has shown to reduce blood pressure; PANCREAZE, a pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency (EPI); STENDRA, approved for erectile dysfunction; and VI-0106, a lead pipeline program for pulmonary arterial hypertension.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivus company profile →
Pulmonx
HQ: United States
Website
- Description: Provider of minimally invasive medical devices and technologies for diagnosing and treating pulmonary disorders, including the Zephyr Valve for severe emphysema to reduce hyperinflation and improve lung function without surgery, and the Chartis System, a bronchoscopy-based diagnostic tool measuring airflow and resistance to assess lung compartments for Zephyr Valve treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pulmonx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inogen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inogen
2.2 - Growth funds investing in similar companies to Inogen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inogen
4.2 - Public trading comparable groups for Inogen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →